1. Home
  2. ARAI vs LSTA Comparison

ARAI vs LSTA Comparison

Compare ARAI & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARAI

Arrive AI Inc.

N/A

Current Price

$0.71

Market Cap

32.3M

Sector

Finance

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$3.11

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAI
LSTA
Founded
2020
1980
Country
United States
United States
Employees
51
N/A
Industry
Diversified Commercial Services
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3M
28.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ARAI
LSTA
Price
$0.71
$3.11
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$12.00
$15.00
AVG Volume (30 Days)
2.4M
62.0K
Earning Date
04-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
$800.66
N/A
Revenue Next Year
$650.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.51
$1.81
52 Week High
$15.50
$5.07

Technical Indicators

Market Signals
Indicator
ARAI
LSTA
Relative Strength Index (RSI) 43.33 33.44
Support Level $0.65 $2.75
Resistance Level $0.81 $3.43
Average True Range (ATR) 0.06 0.14
MACD 0.00 0.05
Stochastic Oscillator 19.95 10.53

Price Performance

Historical Comparison
ARAI
LSTA

About ARAI Arrive AI Inc.

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advance chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: